Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

Porter DL, Levine BL, Kalos M, Bagg A, June CH.

N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998.

2.

[Treatment of lymphoblastic leukemia with CD19-specific modified chimeric antigen receptor T cells].

Li HH, Zhu P, Wu XQ, Liu YF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec;22(6):1753-6. doi: 10.7534/j.issn.1009-2137.2014.06.047. Review. Chinese.

PMID:
25543510
3.
4.

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy.

Dai H, Wang Y, Lu X, Han W.

J Natl Cancer Inst. 2016 Jan 27;108(7). pii: djv439. doi: 10.1093/jnci/djv439. Print 2016 Jul. Review.

5.

CAR T-cells merge into the fast lane of cancer care.

Frey NV, Porter DL.

Am J Hematol. 2016 Jan;91(1):146-50. doi: 10.1002/ajh.24238. Review.

6.

Chimeric antigen receptor T-cell therapy for ALL.

Maude SL, Shpall EJ, Grupp SA.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):559-64. doi: 10.1182/asheducation-2014.1.559. Epub 2014 Nov 18. Review.

PMID:
25696911
7.

Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.

Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419. Review.

PMID:
25901860
8.

Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer.

Marcus A, Eshhar Z.

Expert Opin Biol Ther. 2014 Jul;14(7):947-54. doi: 10.1517/14712598.2014.900540. Epub 2014 Mar 24. Review.

PMID:
24661086
9.

CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia.

Lorentzen CL, Straten PT.

Scand J Immunol. 2015 Oct;82(4):307-19. doi: 10.1111/sji.12331. Review.

10.

Global Manufacturing of CAR T Cell Therapy.

Levine BL, Miskin J, Wonnacott K, Keir C.

Mol Ther Methods Clin Dev. 2016 Dec 31;4:92-101. doi: 10.1016/j.omtm.2016.12.006. eCollection 2017 Mar 17. Review.

Supplemental Content

Support Center